New Horizon Health Limited (HK:6606) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
New Horizon Health Limited has announced significant changes to its leadership team, including the resignation of Prof. Hong Wu as an independent non-executive Director due to personal health reasons, and the appointment of Ms. Jiangnan Kong in multiple roles, effective from October 1, 2024. Ms. Kong, with a strong legal and business background, steps in as an independent non-executive Director and takes charge of the Remuneration and Nomination Committees. The company has also highlighted the continued suspension of trading.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.